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Abstract
The aim of this study was to assess the hepatic portal vasculature visible 
on an intraoperative mesenteric portovenogram. The portovenograms of 
100 animals were independently assessed by two experienced 
observers. Two scoring systems were developed, a subjective visual 
analogue scale and a novel objective scoring system. These two systems 
were assessed for repeatability, reproducibility and interchangeability. 
The portovenograms studied consisted of an initial portovenogram, prior 
to manipulation of the portosystemic shunt, and a second portovenogram 
following temporary full occlusion of the shunting vessel.
The hepatic portal vasculature was compared between the pre-occlusion 
and post-occlusion portovenograms. These findings were used to 
investigate the relationship between portal atresia / hypoplasia and the 
pre-occlusion portovenograms.
The surgical records of the 100 animals were examined and the 
portovenograms of those animals which underwent only partial ligation of 
their portosystemic shunt were compared with those which tolerated full 
ligation.
There was no statistical difference between the two observers when 
scoring the same portovenogram for either the visual analogue scale (P = 
0.730, reproducibility coefficient = 17.85 units) or the objective scoring 
system (scores identical, reproducibility coefficient = 0). There was no 
statistical difference, for either of the observers, when the same 
portovenogram was assessed on two separate occasions using the visual 
analogue scale (observer 1, P = Ô.35, repeatability coefficient = 17.93 
units; observer 2, P = 0.42, repeatability coefficient = 8.27 units) or the 
objective scoring system (scores given by both observers were identical, 
repeatability coefficient = 0 for both observers). The results of comparison 
between the visual analogue scale and objective scoring system
confirmed that the two scoring systems were not directly interchangeable. 
Although both scoring systems demonstrated good reproducibility and 
repeatability, the objective scoring system possessed a number of 
inherent deficiencies that suggested it was not the method of choice for 
the assessment of the subjective data obtained from intraoperative 
mesenteric portovenography.
The pre-occlusion scores were significantly different to the post-occlusion 
scores using both scoring systems (P<0.01 for both). Animals with 
apparent portal atresia / hypoplasia on pre-occlusion portovenography 
were found to have a wide range of scores on post-occlusion 
portovenograms, as high as 98 units using the visual analogue scale and 
13 on the objective scoring system.
The full ligation group had significantly higher portovenogram scores than 
the partial ligation group both pre- and post-occlusion, using either 
scoring system (P<0.01 for all tests).
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Introduction
This study aims to investigate the use of intraoperative mesenteric 
portovenography in the diagnosis and surgery of portosystemic shunts 
(PSS) in the dog and cat. In particular, the appearance of the hepatic 
portal vasculature (HPV) will be assessed and evaluated, before and after 
temporary occlusion of the shunting vessel, in order to investigate the 
incidence of portal vein atresia and hypoplasia. Two methods for defining 
the degree of HPV were devised. The novel objective scoring system 
(OSS) of the HPV was compared with a subjective visual analogue scale 
(VAS) for repeatability, reproducibility and agreement. Comparisons of 
the groups of animals undergoing full and partial ligation of their PSS 
were also undertaken in an attempt to consistently and safely identify 
animals which will tolerate full ligation of their PSS.
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Literature Review
Portosystemic shunts are abnormal vascular communications between 
the portal circulation, which drains the gastrointestinal tract, and the 
systemic circulation. They allow blood from the intestines, spleen and 
pancreas containing nutrients, hormones, toxins, bacteria and oral drugs 
to bypass the liver which would normally utilise, modify or remove them 
(Vulgamott, 1986). Portosystemic shunts were first identified in the dog in 
1949, as an incidental finding during post mortem examination (Hickman 
and others, 1949). Subsequently Ewing and others (1974) reported the 
condition in dogs and these authors attempted to define the different 
types of PSS in the dog using various angiographic methods and post 
mortem examinations. No attempts were made to manage the condition 
in these cases.
Anatomy of the Liver and Portal Venous System
Gross Anatomy
The liver constitutes three to four per cent of the bodyweight in adult 
animals, while in younger animals it is relatively heavier. It lies in the 
cranial abdomen apposed to the diaphragm cranially, with the stomach, 
pancreas, duodenum and right kidney immediately caudal to it. 
Classically, the liver is divided into four lobes (left, quadrate, right and 
caudate), four sublobes (left lateral, left medial, right medial and right 
lateral) and two processes (caudate and papillary processes of the 
caudate lobe) (Evans, 1993). Figure 1 shows the arrangement of the 
lobes of the liver in the dog.
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Figure 1: The lobes of the liver in the dog, view from the visceral surface. Key: CC -  
caudate process of caudate lobe, RL -  right lateral lobe, RM -  right medial lobe, Q -  
quadrate lobe, GB -  gall bladder, LM -  left medial lobe, LL -  left lateral lobe, PC -  papillary 
process of caudate lobe.
Sleight and Thomford (1970) divided the liver into three divisions defined 
by the hepatic arterial supply. By this classification the right division 
contains the caudate process of the caudate lobe and the right lateral 
lobe, the central division contains the right medial and quadrate lobes and 
the left division contains the left medial and left lateral lobes (Figure 2).
Central division
RM Left
divisionLM
Right
division RL
LLCC
Figure 2: The divisions of the liver in the dog, view from the visceral surface. Key: CC -  
caudate process of caudate lobe, RL -  right lateral lobe, RM -  right medial lobe, Q -  
quadrate lobe, LM -  left medial lobe, LL -  left lateral lobe, PC -  papillary process of caudate 
lobe.
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The liver is attached to the diaphragm cranially by the coronary ligament, 
which surrounds the CVC as it passes through the caval hiatus, and also 
by the right and left triangular ligaments. The falciform ligament also has 
its origins at the ventral part of the coronary ligament and the diaphragm 
before passing to the umbilicus. Sleight and Thomford (1970) suggested 
the main attachment is the left triangular ligament because the right 
triangular ligament is very small and the falciform ligament between the 
diaphragm and liver is absent in fifty per cent of dogs.
Vasculature
The afferent blood supply to the liver consists of the portal venous system 
and the hepatic arteries. The portal blood comprises 75-80 per cent of 
total hepatic blood flow and provides 50 per cent of the oxygen supply, as 
well as nutrients and hormones which maintain the liver (Payne and 
others, 1990). The hepatic arterial flow, although only a minor proportion 
of total flow, is essential and death will ensue if it is occluded without the 
use of antibiotics (Evans, 1993). The portal vein is relatively constant in 
location and structure. In the dog, it originates at the conjunction of the 
cranial and caudal mesenteric veins, at the root of the mesentery, before 
receiving tributaries from the splenic vein and gastroduodenal vein (Kalt 
and Stump, 1993). At the porta of the liver, the portal vein provides a 
branch (right main branch) which further ramifies before entering the right 
lateral lobe and the caudate process of the caudate lobe. The main portal 
trunk continues to the left providing branches to the right medial lobe, 
papillary process of the caudate lobe, quadrate lobe, left medial lobe, 
ending in the left lateral lobe (Figure 3) (Sleight and Thomford, 1970; Kalt 
and Stump, 1993). In the cat, the portal vein receives tributaries from the 
cranial mesenteric and caudal mesenteric, splenic, gastroduodenal and 
cranial pancreaticoduodenal veins. At the porta of the liver it trifurcates, 
sending one branch to the caudate lobe, one to the right lateral and right
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medial lobes and the final branch supplies the left division (Perry and 
Lowrie, 1993).
Branch to right 
medial lobe
y Left branchiMUt
a
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Extrahepatic 
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Figure 3: Anatomy of the intrahepatic portal vein in the dog, ventrodorsal view.
The hepatic arteries originate from the celiac artery and show 
considerable variation in their branching pattern. The hepatic artery 
descends towards the porta of the liver where it forms an arch usually 
passing ventral to the portal vein. The number of branches arising from 
the arch varies considerably, from one trunk, which then splits to provide 
branches to each lobe, up to five separate branches. Two or three 
branches are the most common configurations (Sleight and Thomford, 
1970; Schmidt and others, 1980).
There are normally six to eight hepatic veins of significant size and 
numerous other tiny tributaries. The most consistent vessel is the left 
hepatic vein which drains the left divisional hepatic lobes and is also 
described as draining the quadrate and right medial lobes in some dogs 
(Evans, 1993). It enters the vena cava on the ventral surface at the left 
side and is the most cranial of the hepatic veins (Swalec Tobias and
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Rawlings, 1996). The remaining hepatic veins, further caudal, are of an 
inconsistent position and drainage (Sleight and Thomford, 1970).
In the prenatal and neonatal animal at least fifty per cent of oxygenated 
placental blood is allowed to bypass the hepatic sinusoids by way of the 
ductus venosus. The umbilical vein terminates in the left branch of the 
portal vein. The ductus venosus is a straight vessel of uniform diameter 
which passes from the left branch of the portal vein (opposite the 
umbilical vein) between the left lateral lobe and papillary process of the 
caudate lobe into a venous dilatation (ampulla) at the confluence of the 
ductus venosus, left hepatic vein and left phrenic vein. This ampulla then 
drains into the vena cava. The ductus venosus is normally functionally 
closed by three days post partum and anatomically closed by six days 
(Burton and White, 1999).
Embryology of the Abdominal Veins
Normal Development
Three main embryological venous systems, the cardinal, vitelline and 
umbilical systems, form all the major abdominal veins. The formation of 
these veins by degeneration, anastomosis and persistence of 
embryological vessels is driven by the pattern of the flow of blood itself 
and so any minor changes in the development of the embryo may cause 
major changes in the eventual form of the vessels.
The portal vein is derived from the vitelline veins, which are originally 
paired (left and right) veins with three anastomoses connecting the two. 
It is formed from the caudal portion of the left vitelline vein, the middle 
anastomosis and the cranial portion of the right vitelline vein. The vitelline 
veins also form the hepatic veins and the hepatic and posthepatic caudal 
vena cava (CVC). These are normally separated from the portal vein by 
the developing hepatic sinusoids (Payne and others, 1990; Hunt and 
others, 1998a). The intrahepatic portal venous system is formed
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predominantly from the vitelline veins. The left branch of the intrahepatic 
portal vein, between its termination in the left lobe and the ductus 
venosus, develops from the umbilical-portal sinus which is of both vitelline 
and umbilical origin (Payne and others, 1990).
There are initially two umbilical veins but the right umbilical vein 
degenerates. The cranial portion of the left umbilical vein forms the 
ductus venosus which connects the portal sinus and the left hepatic vein 
until after birth. Cranial to the liver both veins degenerate meaning all 
umbilical blood flow to the heart passes via the ductus venosus (Payne 
and others, 1990).
The cardinal system consists of three pairs of veins, the caudal cardinal, 
the supracardinal and the subcardinal veins. The supracardinal and 
subcardinal veins develop in association with the mesonephros and both 
connect to the caudal cardinal veins cranially. When the mesonephros 
degenerates and the metanephros develops the vascular segments 
degenerate and anastomose to form the adult veins. The prerenal (caudal 
to the kidneys) CVC is formed from the right supracardinal vein, the renal 
segment from the anastomosis of both right supracardinal and 
subcardinal veins and the prehepatic CVC (between the kidneys and the 
liver) develops from the right subcardinal vein. Where the prehepatic 
(cardinal) and hepatic (vitelline) segments of the CVC Join is the only 
normal connection between the vitelline and cardinal venous systems 
caudal to the liver. The precursor of the azygos vein is the right caudal 
cardinal vein, this is connected to the supracardinal vein early in 
development but the intervening segment degenerates to ensure 
separation of the azygos vein and CVC.
Classification of Portosystemic Shunts
Portosystemic shunts have been classified in several different ways: 
acquired or congenital, multiple or single and intrahepatic or extrahepatic.
Congenital PSS are present at birth, usually single or double, and can be
17
either intrahepatic or extrahepatic. Acquired PSS are usually not present 
at birth because they develop secondarily to conditions leading to raised 
portal pressure. They have been associated with hepatic parenchymal 
disease, hepatic arteriovenous fistulae and surgical manipulation of 
congenital PSS (Van den Ingh and others, 1995). They are narrow, 
tortuous vessels commonly found connecting the two venous systems 
close to the left kidney and are found in large numbers. Multiple 
congenital PSS have been described (Hunt and others, 1998b) but are 
uncommon. The majority of congenital PSS are single vessels although 
double congenital PSS do exist and comprised 11 per cent of PSS in one 
report (Johnson and others, 1987). Meyer and others (1999) described 
two dogs in which a second shunting vessel was demonstrated. These 
dogs had continued evidence of shunting despite ligation of a PSS 
previously.
Although the differenzbe tween intrahepatic and extrahepatic PSS 
appears to be simply whether the shunting vessel is within the liver 
parenchyma or not, intrahepatic PSS are more correctly defined as those 
which originate from the portal vein branches after their bifurcation 
(trifurcation in cats) at the porta of the liver (Hunt and others, 2000). This 
definition will then include those PSS which may not actually pass 
through the liver parenchyma itself. Intrahepatic PSS are usually 
classified by the division of the liver through which they pass (Swalec 
Tobias and Rawlings, 1996; White and others, 1998; Lamb and White, 
1998). Left divisional PSS follow a pattern consistent with continued 
patency of the ductus venosus (White and Burton, 2000). Several authors 
have described all intrahepatic PSS as PDVs (Rothuizen and others, 
1982; Martin and Payne, 1990; Payne and others, 1990) but as there 
appears to be no embryological basis for this structure in the right or 
central divisions, it is likely that PSS passing through these divisions are, 
in fact, anomalous vessels or bizarre sinusoidal malformations (Burton 
and White, 1999). Central divisional PSS in dogs, often take the form of a 
window-like connection between the dilated portal branch and hepatic
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vein or vena cava. Central divisional PSS in cats and right divisional PSS 
in dogs and cats most often take the form of a tortuous vessel forming a 
loop entirely within one of the lobes (Lamb and White, 1998).
Extrahepatic PSS are always abnormal vessels, which can arise from 
anywhere in the portal circulation. They are often large tortuous vessels 
and commonly originate from the portal, left gastric, splenic, cranial 
mesenteric, caudal mesenteric, colonic, umbilical or gastroduodenal veins 
(Payne and others, 1990). They usually insert directly into a systemic 
vein, most commonly the CVC (portocaval) or the azygos vein 
(portoazygos) (Johnson and others, 1987). They can, however, drain into 
more obscure vessels such as the internal thoracic, renal or colonic veins 
(Berger and others, 1986). The portal vein cranial to the PSS may appear 
hypoplastic or may be completely absent as in cases of portal atresia 
(Hunt and others, 1998a). Portocaval shunts can often be located at the 
epiploic foramen whereas portoazygos shunts can be found by opening 
the omental bursa and observing any vessel crossing the diaphragm 
(Swalec Tobias and others, 1998).
Two further types of hepatic vascular anomalies have been described. 
Hepatic microvascular dysplasia is characterised by presentation with 
clinical signs consistent with portosystemic shunting but with no evidence 
of a macroscopic PSS, angiographically or at surgery. Diagnosis is by 
histopathology with the portal veins and hepatic veins connected at a 
microvascular level (Phillips and others, 1996; Schermerhorn and others, 
1996; Christiansen and others, 2000). Hepatic arteriovenous (or 
arterioportal) fistulae are direct connections between the hepatic arteries 
and portal (or hepatic) vein, usually within a single lobe and can be 
congenital or acquired (Bailey and others, 1988). This produces dilated 
vessels within the parenchyma of this lobe, hepatofugal portal flow and 
portal hypertension usually leading to the development of multiple 
acquired PSS. Clinical signs are consistent with portal hypertension, such 
as ascites, and treatment is by removal of the affected lobe.
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Portal Atresia and Portal Hypoplasia
Portal atresia is the total absence of a portal vein between the PSS and 
the liver (Hunt and others, 1998a). This is an uncommon finding with 
published incidences of 6.8 per cent (Hunt and others, 1998a) and 7.4 
per cent (Center and Magne, 1990) of dogs with PSS. The very first 
reported finding of PSS also had portal atresia (Hickman and others, 
1949). Hunt and others (1998a) described five dogs with portal atresia, in 
four of these the portal vein inserted directly into the CVC and in the other 
case it joined the left hepatic vein. If the PSS were closed in these 
animals then fatal portal hypertension would invariably result, this means 
that no surgical correction of the problem is possible. Hunt and others 
(1996) also identified a case with an intrahepatic PSS which had 
intrahepatic portal atresia, this was euthanased.
Portal hypoplasia describes portal vessels which are narrower or less well 
developed than normal. Primary portal hypoplasia has been reported in 
42 dogs in which it was thought to be the cause of portal hypertension 
and multiple acquired PSS (Van den Ingh and others, 1995). It is more 
commonly found secondary to reduced portal blood flow, usually as a 
consequence of a PSS. It affects the portal vein proximal to the PSS 
including the HPV. Secondary portal hypoplasia was a finding in several 
case series of animals with PSS (Ewing and others, 1974; Gofton, 1978; 
Rothuizen and others, 1982). This was either observed at surgery or 
portovenography demonstrated little or no HPV. Breznock (1979) also 
found portal hypoplasia but described it as portal atresia despite some 
portal flow being present through the vessels. In this same study 
improved visualisation of the HPV was demonstrated angiographically 
several weeks after surgical attenuation or closure.
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Embryology of Portosystemic Shunts and Vascular Anomalies
Patent ductus venosus (PDV) is due to the failure of closure of the normal 
embryological structure the ductus venosus. Multiple acquired PSS are 
normal microscopic portosystemic communications which open in 
response to portal hypertension (increased blood pressure in the portal 
system). All other types of PSS are abnormal embryological connections. 
Other types of intrahepatic PSS (right and central divisional) may be due 
to failure of the hepatic sinusoids to separate the portal and caval 
portions of the vitelline vein, as normally occurs. They may be a remnant 
of the embryonic vitelline vein or a sinusoidal malformation (White and 
others, 1998). All extrahepatic PSS are abnormal connections between 
the vitelline and cardinal venous systems (Payne and others, 1990). This 
may be due to changes in embryological blood flow encouraging 
abnormal anastomoses between the vitelline and cardinal systems. Hawe 
and Mullen (1984) postulated that a delay in formation of the anastomosis 
between the left and right vitelline veins may have encouraged 
anastomosis with the cardinal veins to allow adequate venous flow, thus 
creating the PSS.
True portal atresia commonly involves the insertion of the portal trunk 
(vitelline system) into the prehepatic CVC, derived from the right 
subcardinal vein. The right subcardinal vein anastomoses with the 
hepatic CVC (vitelline origin) normally, so this vessel may have a special 
affinity for anastomosis with the vitelline system (Hunt and others, 
1998a). For the animal to suffer from portal atresia, degeneration or 
aplasia of the vitelline system between the shunting vessel and the 
hepatic veins must also occur. Some reports of portal atresia describe 
insertion of the portal trunk into the left hepatic vein, this is a normal 
vitelline to vitelline anastomosis but the abnormality may be due to 
persistence of the left rather than right vitelline vein and failure of closure 
of the ductus venosus (Hunt and others, 1998a).
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Diagnosis
Signalment
Animals with congenital PSS usually present at a young age, although 
some do not show clinical signs until later in life (Center and Magne, 
1990). Acquired PSS, although often presenting in the older animal, have 
also been diagnosed in very young animals (Rand and others, 1988). 
Most case series’ reported no significant sex predilection for PSS 
(Johnson and others, 1987; Center and Magne, 1990). Some have 
suggested that large breed dogs are likely to have intrahepatic PSS and 
small breed dogs extrahepatic PSS (Bostwick and Twedt, 1995; Lamb, 
1996). There are, however, exceptions to this rule (Center and Magne, 
1990; White and others, 1998; Hunt and others, 2000). Some breeds are 
reported as having a higher incidence of intrahepatic PSS in the UK 
including golden and Labrador retrievers (central, right and left divisional 
PSS), Irish wolfhounds (PDV) and Old English sheepdogs (central 
divisional PSS) (White and others, 1998). In the US, Yorkshire terriers 
and miniature schnauzers have a high incidence of extrahepatic PSS 
(Center and Magne, 1990). In Australia, the Australian Cattle dog has a 
high incidence of right sided intrahepatic PSS and Maltese terriers are 
also over-represented with extrahepatic PSS (Tisdall and others, 1994). A 
survey of 160 dogs in the Netherlands revealed the commonest small 
breeds were Yorkshire, Cairn and Maltese terriers and large breeds were 
golden retrievers. Old English sheepdogs, Bernese mountain dogs and 
Irish wolfhounds (Wolschrijn and others, 2000). Irish wolfhounds in the 
Netherlands are the only breed to have had an inheritance of the disease 
demonstrated (Meyer and others, 1995). In cats, PSS are commonly 
found in domestic short hairs, Persians and Siamese. Extrahepatic PSS 
arising from the left gastric vein and intrahepatic PSS are common, but 
other types have been reported as well as variation between the breeds 
(Levesque and others, 1982; Berger and others, 1986; Scavelli and 
others, 1986; VanGundy and others, 1990).
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Clinical Signs
Animais with PSS predominantly show signs associated with the nervous, 
gastrointestinal and urinary systems. They are usually episodic in nature 
and associated with the ingestion of protein-rich food, gastrointestinal 
bleeding, and periods of constipation or dehydration (Center and Magne, 
1990; Watson, 1997). The list of reported clinical signs is large and 
varied. Neurological signs are predominantly due to hepatic 
encephalopathy and include depression, bizarre behaviour, 
hyperexcitability, apparent hallucinations, amaurotic blindness, ptyalism, 
ataxia, weakness, stupor, head pressing, staring, repetitive pacing and 
circling, aggression, grand mal seizures and coma (Vulgamott, 1985; 
Center and Magne, 1990; Watson, 1997). The pathophysiology of hepatic 
encephalopathy is not as yet fully understood. Current theories which 
have been suggested are ammonia acting as a neurotoxin with or without 
other synergistic toxins, alteration of monoamine neurotransmitters due to 
a change in aromatic amino acid metabolism, alteration in amino acid 
neurotransmitters, y-aminobutyric acid and glutamate and increased 
cerebral levels of endogenous benzodiazepine-like substances 
(Maddison, 1992). Previous theories such as false neurotransmitters, 
decreased cerebral energy levels, lack of a brain protective factor and 
changes in the blood brain barrier are not currently favoured (Maddison, 
1992). Gastrointestinal signs include intermittent anorexia, polyphagia, 
pica, vomiting, diarrhoea and constipation (Vulgamott, 1985; Maddison, 
1992). Urinary tract signs include polyuria and polydipsia, which is 
postulated to be caused by either a low urea level resulting in a 
decreased medullary concentration gradient, psychogenic polydipsia, or 
derangement of hepatic metabolism of renin and adrenal steroids 
(Vulgamott, 1985; Watson, 1997). Haematuria and pollakiuria are caused 
by ammonium biurate uroliths present due to the impaired metabolism of 
ammonia and urea by the liver. Other commonly seen signs are failure to 
grow as well as littermates and intolerance to certain drugs, especially 
anaesthetics and tranquillisers. Rarer signs include weight loss, 
intermittent pyrexia, recurrent apparent upper respiratory tract problems
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in the cat, intense pruritus in the dog, and jaundice and ascites in cases 
of acquired PSS (Center and Magne, 1990).
Physical Examination
Clinical examination of animals with PSS is often unremarkable. 
However, small stature, renomegaly, difficulty palpating a liver margin 
and bladder calculi may be detected. Affected cats commonly have a 
characteristic copper coloured iris (Center and Magne, 1990). Many 
animals are first presented with neurological deficits such as central 
blindness or are in the post-ictal phase of a seizure.
Clinical Pathology
The results of routine haematology, biochemistry and urinalysis do not 
definitively diagnose a PSS but may raise the index of suspicion for the 
clinician. Haematological abnormalities consist of mild anaemia and 
erythrocyte microcytosis. Postulated explanations for this include 
alteration in iron metabolism and altered erythrocyte production or 
survival. Poikilocytosis has been reported to occur commonly in cats and 
also in some dogs (Center and Magne, 1990). Biochemical changes are 
more varied. Alanine aminotransferase, aspartate aminotransferase and 
alkaline phosphatase (ALP) may all be mildly elevated, although in 
younger animals the raised ALP may be extrahepatic in origin (bone). 
Blood urea and glucose levels are often low.
Two dynamic biochemical tests are available to diagnose PSS, both are 
highly specific. The first, the ammonia tolerance test involves measuring 
fasting blood ammonia level then giving ammonium chloride either by 
stomach tube (100 mg/kg at 20 mg/ml or less) or into the rectum (2 ml/kg 
of 5 per cent solution). Further samples are then taken after 30 minutes 
for the oral test, or 20 and 40 minutes for the rectal method (Leveille- 
Webster, 2000). Dynamic serum bile acid measurement requires a fasted 
blood sample and a further sample two hours after feeding a meal
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(Leveüle-Webster, 2000). In both tests the results are usually significantly 
raised for both samples in PSS. In the normal animal, ammonia is almost 
completely removed from the portal circulation by the liver. When blood 
bypasses the liver, ammonia remains at higher concentrations. Bile acids 
are released from the gall bladder when a meal is ingested and are 
subsequently reabsorbed from the Gl tract and returned to the liver, via 
the portal vein, to be recycled. In cases of PSS, they remain in the 
systemic circulation for longer and in higher concentrations. Both 
ammonia and bile acid concentrations are sensitive indicators of 
portosystemic shunting but the latter is often preferred because bile acids 
are stable in blood for longer periods (Center, 1990). There are 
documented deficiencies of the ammonia tolerance test, it may precipitate 
an encephalopathic crisis itself and oral administration of ammonium 
chloride can cause vomiting, invalidating the test (Center, 1990).
Urinalysis reveals a variable specific gravity (hypersthenuria, isosthenuria 
or hyposthenuria). Ammonium biurate crystalluria or urolithiasis is also 
commonly found in animals with PSS (Center and Magne, 1990).
Radiography
Plain abdominal radiography may reveal microhepatica, renomegaly and 
loss of detail in the abdomen due to lack of intra-abdominal fat. Urate 
uroliths are radiolucent and so are not easily visible on plain films. 
Definitive diagnosis of a PSS relies on accurate imaging of the portal 
venous system to demonstrate the anomaly. Angiography is described as 
the definitive means for diagnosing, locating and determining the extent 
of a PSS (Moon, 1990). The functions of portovenography are to 
demonstrate the presence of a PSS, to document whether it is 
intrahepatic or extrahepatic, to determine its location (the affected vessels 
for extrahepatic PSS or the hepatic division for intrahepatic PSS), to 
determine its morphology (especially important for intrahepatic PSS) and 
to assess the status of the HPV. Birchard and others (1989) found, using
portovenography, that if the caudal extent of a shunting vessel was
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cranial to the vertebra of the 13^ thoracic vertebra (T13) it was likely to be 
intrahepatic and if it was caudal to T13 it was likely to be extrahepatic. 
Angiography may also be used to monitor cases after surgery. It can be 
used to assess the patency of the shunting vessel, assess any 
improvement in the HPV and diagnose any acquired PSS which may 
have been formed (Martin and Payne, 1990). As this is an invasive 
procedure, however, it is usually only performed in animals showing 
clinical signs or with abnormal biochemistry or scintigraphy results, often 
in conjunction with repeat surgery.
In humans, many different angiographic procedures have been 
developed to investigate the different vascular systems of the liver. The 
hepatic circulation has a major effect on liver regeneration, metabolism 
and histology, thus angiography is of great value in assessing patients 
with hepatic fibrosis, cirrhosis, chronic active hepatitis, neoplasia, portal 
hypertension and PSS. Several indications for angiography in humans 
have now been superseded by the use of ultrasonography (Schmidt and 
Suter, 1980). The choice of techniques available for humans is very wide 
encompassing techniques which highlight arteries, hepatic veins and the 
portal vein either directly or indirectly (Table 1). Only a small number of 
these techniques have gained widespread use in veterinary medicine.
Table 1: Human hepatic angiography methods (Veterinary options in bold) (Schmidt and 
Suter, 1980)
Arteriography ÿidireçt Portography Direct Portography Venography Panangiography
Selective celiac 
arteriography
Arterial
portography
Operative
mesenteric
portography
Free hepatic vein 
catheterisation
Percutaneous
kinetic
hepatography
Superseiective
hepatic
arteriography
Splenoportography Percutaneous
transhepatic
portography
Wedge hepatic 
vein
catheterisation
Umbilical vein 
portography
Transjugular
transhepatic
portography
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The indications for hepatic angiography in animals include portal 
hypertension with ascites, hepatic encephalopathy and PSS (Schmidt 
and Suter, 1980).
Arteriography in cats and dogs is most useful in the diagnosis of 
arterioportal or arteriovenous fistulae. Superseiective catheterisation of 
the hepatic artery gives a better quality image, reducing superimposition 
of other vessels. Arterial portography, most commonly cranial mesenteric 
arterial portography, may be used in the demonstration of PSS. Both 
arteriography techniques are minimally invasive, using the femoral artery 
to enter the aorta. The only minor complication is haematoma formation 
at the site of puncture and this can be minimised by cutting down onto the 
vessel. Special catheters and fluoroscopy or a cut film changer are 
required. It can be quite technically demanding to successfully place the 
catheter tip, especially if superseiective catheterisation is attempted. 
Image quality is satisfactory but compared to direct portovenography 
there is superimposition of the arteries over the portal venous system and 
the density of the contrast in the portal system is diminished due to 
dilution as it passes through the capillaries (Suter, 1975; Schmidt and 
Suter, 1980),
Splenoportography involves placing a catheter into the splenic pulp 
before injecting contrast medium, this can be achieved either 
percutaneously or at laparotomy. The percutaneous method is unsuitable 
for cats and can be difficult in some dogs, as it can lead to puncture of
other abdominal structures and haemorrhage from the puncture sites.
These problems can be avoided by using ultrasound guidance or by 
placing the catheter at full or mini-laparotomy. The advantages of the
technique are that it is minimally invasive when performed
percutaneously, highlights most PSS with the exception of mesenteric to 
systemic PSS, and is very useful for assessing the direction of portal 
blood flow. Compared to other techniques, filling of the hepatic portal vein 
branches can be poor, due to the slow rate of drainage of contrast from
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the splenic parenchyma. Contrast density is not as good as the direct 
methods and superimposition of the spleen can occur in lateral views 
(Schmidt and Suter, 1980).
Umbilical vein portovenography requires cannulation of the umbilical vein 
and as such is restricted to use in neonatal animals, usually as a 
research tool (Suter, 1975). Image quality is good but the flow of contrast 
is non-physiological (Burton and White, 1999).
Operative mesenteric portovenography is performed by catheterising a 
mesenteric vein at laparotomy. This method provides excellent detail of 
the portal vein in a physiological manner (Schmidt and Suter, 1980). The 
disadvantages of this technique are the requirements for laparotomy and 
sacrifice of a mesenteric vein. This technique is preferable to 
splenoportography if a laparotomy is to be performed and is often 
combined with surgery.
Techniques used in human patients which have not gained widespread 
use in veterinary medicine include percutaneous transhepatic 
portovenography, where the portal vein at the hilus of the liver is directly 
catheterised, transjugular transhepatic portography, in which the catheter 
is passed through the jugular vein, right atrium, hepatic vein and 
parenchyma into a portal vein, hepatic vein catheterisation, where a 
hepatic vein is catheterised through the jugular and percutaneous kinetic 
hepatography where a long needle is placed deep in the parenchyma and 
slowly withdrawn while injecting contrast. These have all met with 
sufficient drawbacks to minimise their use in animals (Schmidt and Suter, 
1980).
The most commonly used veterinary techniques for PSS visualisation 
have been reviewed by Moon (1990). These include operative jejunal 
portovenography, splenoportography, cranial mesenteric arterial 
portography and superseiective hepatic arterial catheterisation. The most
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commonly performed techniques are splenoportography and operative 
mesenteric portovenography as these require the least equipment and 
expertise. In recent years, newer imaging technologies have been 
introduced to improve the detection of PSS. Subtraction portovenography 
improves visualisation of the shunting vessel which is undoubtedly useful 
for inexperienced observers but the extra time or expensive equipment 
mean that it is not an essential technique (Wrigley and others, 1987; 
Swalec Tobias and others, 1996). Seguin and others (1999) utilised 
magnetic resonance angiography (MRA) for the diagnosis of PSS. This 
technique uses the MRI scanner to create contrast in the portal vein 
without the need to introduce foreign agents into the animal. It has 
enormous potential as it is minimally invasive, obviating the need for 
contrast materials which may produce side effects. However, general 
anaesthesia is still necessary, further experimentation is required to 
produce the best results and in most cases it will be prohibitively 
expensive for some time to come.
Ultrasonography
The use of abdominal ultrasonography in the diagnosis of PSS is 
becoming more widespread. It has the advantage of being a non-invasive 
technique which in the hands of experienced operators provides a 
tremendous amount of information regarding the type, location and 
morphology of the shunting vessel (Lamb, 1998). Knowledge of the 
morphology of intrahepatic PSS before surgery is helpful in selecting the 
correct procedure and allows advanced preparations to be made. One 
study of 63 cases (Holt and others, 1995) correlated ultrasound findings 
with surgical, portovenographlc and post mortem findings and found a 
sensitivity for detection of extrahepatic PSS of 81 per cent and a 
specificity of 66.7 per cent. For detection of intrahepatic PSS the 
sensitivity was 100 per cent. Colour flow Doppler and Doppler 
measurement techniques can greatly ease the identification of PSS but 
also require an experienced operator (Lamb, 1996).
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Nuclear Scintigraphy
The degree of portosystemic shunting of blood can be quantified using 
portal scintigraphy. Technetium®^ labelled molecules are introduced into 
the portal system, either transcolonically or percutaneously into the 
splenic vein, and a gamma camera is used to monitor the change in 
radioactivity in the liver and heart. In animals with PSS the rise in activity 
in the heart precedes the liver, the opposite of normal animals. The 
degree of shunting can be estimated by comparing the rise in activity in 
the two organs. Portal scintigraphy, however, cannot determine the type 
of PSS, this requires a further diagnostic procedure (Moon, 1990; Van 
Vechten and others, 1994; Forster-van Flijfte and others, 1996). This 
technique has been used to monitor progressive changes in shunting 
after partial ligation of PSS (Van Vechten and others, 1994).
Surgical Visualisation
Experienced surgeons will often be able to locate PSS without the need 
for portovenography (Martin and Freeman, 1987; Bellenger and others, 
1995). Many extrahepatic PSS occupy relatively consistent anatomical 
locations within the abdomen (Swalec Tobias and others, 1998). 
Intrahepatic PSS not immediately visible can be located by palpating a 
soft spot in the parenchyma of the affected lobe, observing indentations 
which move in time with breathing, examining the portal or hepatic vein 
for dilatation and locating fluid thrills over the PSS (Breznock and others, 
1983; Swalec Tobias and Rawlings, 1996). Occluding the various portal 
vein branches while monitoring changes in haemodynamic 
measurements (portal pressure, central venous pressure (CVP)) may 
also indicate which portal vein branch supplies the PSS (Breznock and 
others, 1983).
Treatment
Treatment of PSS can be by medical management to alleviate the clinical 
signs or by surgical narrowing or closure of the shunting vessel.
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Medical Treatment
Medical treatment is often implemented to stabilise an animal for surgery, 
in conditions where surgery is contraindicated (multiple acquired PSS) 
and where surgery is declined. The aim of the treatment is to control the 
clinical signs of hepatic encephalopathy (Taboada and Dimski, 1995). 
There are three main areas of medical therapy, dietary change, oral 
antibiotics and oral lactulose (Watson, 1997). A reduced protein diet is 
instituted to reduce blood levels of ammonia and aromatic amino acids 
and the post-prandial peaks. Oral antibiotics, such as ampicillin, alter the 
bacterial flora of the intestines to reduce bacterial ammonia production. 
Lactulose reduces ammonia levels by decreasing production and 
absorption, trapping ammonia in the colon and altering bacterial flora 
(Johnson, 2000).
Surgical Treatment
It is generally agreed that surgery is the best treatment option for PSS. 
Surgical ligation of a PSS can recreate the normal portal system and thus 
allow the liver to regenerate, obviating the need for continued medical 
therapy.
Attenuation of extrahepatic PSS is usually much more straightforward 
than Intrahepatic PSS. The vessels are usually easily visible and 
accessible and require little dissection to allow ligature placement. 
Intrahepatic PSS may require considerable dissection through the liver 
parenchyma and can involve intravascular surgery, total hepatic vascular 
occlusion and thoracotomy.
The aim of surgical treatment is to narrow or, if possible, completely close 
the PSS. In the majority of cases the shunting vessel cannot be 
completely closed. This is because the HPV is unable to accommodate 
the increased blood flow and portal hypertension will result. If severe, this
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will progress to hypovolaemic shock and will be fatal unless the ligature is 
removed. Milder portal hypertension will lead to formation of multiple 
acquired PSS and continuing signs of hepatic encephalopathy. To 
overcome these problems several methods of vessel attenuation have 
been proposed.
For the majority of the last twenty years silk has been the most commonly 
used ligation material. To reduce the incidence of complications, 
guidelines have been published on physical and haemodynamic 
parameters which should avoid excessive portal hypertension. Mathews 
and Gofton (1988) reported the visual signs of portal hypertension as 
splanchnic visceral pallor or cyanosis (particularly the pancreas), 
intestinal hypermotility, increased jejunal artery pulsation and congestion 
of splanchnic veins. Many authors have provided recommendations of 
maximum post ligation portal pressures, and increases in portal pressure, 
which should avoid portal hypertension (Breznock and others, 1983; 
Birchard, 1984; Martin and Freeman, 1987; Butler and others, 1990; 
Bostwick and Twedt, 1995). Accepted recommendations are that the 
portal pressure should not exceed 20 cm of water or the increase in portal 
pressure should not be greater than 10 cm of water. White and others 
(1998) discussed the unreliability of this method of judging attenuation 
and recommended visual assessment of viscera and assessment of the 
systemic arterial blood pressure and CVP (Swalec and Smeak, 1990).
Some partially ligated PSS will, with time, close completely without further 
manipulation (White and others, 1998; Meyer and others, 1999). Others 
may be fully ligated at a second surgery, while a final group will not 
tolerate any further narrowing (White and others, 1998). Silk is thought to 
provoke an acute inflammatory reaction within the vessel wall which lasts 
approximately seven days, followed by a fibroblastic reaction until day 
fifteen. This is proposed to produce further closure by scar formation and 
contracture (Van Vechten and others, 1994). However, in an 
experimental study (Youmans and Hunt, 1999), it was demonstrated that
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a silk ligature did not cause progressive attenuation of a femoral vein. 
This may be due to different conditions between the leg and the 
abdomen, or different blood flow patterns.
In an attempt to produce slow, progressive attenuation after a single 
procedure, two further materials have been used, the ameroid constrictor 
(AC) and cellophane.
The AC is a ring of casein, a hygroscopic clay, which expands when 
exposed to tissue fluid. It is contained in a metal ring to direct the 
expansion to close the central hole, gradually occluding the vessel in the 
middle. The exact length of time to complete closure of the vessel has not 
been reliably documented, as such, controversy remains over whether 
attenuation can occur too rapidly. The AC has been shown to produce 
progressive attenuation of PSS. Youmans and Hunt (1999) found the AC 
completely occluded the femoral vein in two weeks, whereas Vogt and 
others (1996) reported that splenic veins became occluded by four to five 
weeks and half of extrahepatic PSS by 30 days. The central hole is not 
completely obliterated, so it is possible that this relies on thrombus 
formation to completely close the vessel. The reported mortality rate of 14 
per cent and the rate of formation of acquired PSS, also 14 per cent (Vogt 
and others, 1996), using the AC compare less favourably with the 2.1 per 
cent reported for extrahepatic PSS ligated with silk (Hunt and Hughes, 
1999). Possible reasons for this include too rapid closure of the vessel 
leading to fatal hypertension or acquired PSS, or kinking of the vessel by 
the ring causing immediate total occlusion and fatal portal hypertension.
Cellophane banding Involves wrapping a strip of cellophane around the 
vessel and securing this with a titanium clip. This was first discussed by 
Breznock in 1979, and has been shown to produce progressive 
attenuation over four to six weeks (Youmans and Hunt, 1999), causing a 
chronic foreign body inflammatory reaction and subsequent contracture 
and thrombus formation.
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A final method of attenuation reported is the implantation of thrombogenic 
coils into the PSS. This has been described for the closure of a PDV. It 
involves passing a long catheter through the jugular vein into the ductus 
venosus under fluoroscopic guidance. The coils are then positioned in the 
shunt through the catheter, usually two coils per procedure. In this report 
(Partington and others, 1993) four separate procedures were required to 
finally close the PSS, but the authors thought that with better coil size 
selection and greater experience it could be performed in just two 
procedures. The coil caused progressive closure due to thrombus 
formation. This procedure is less invasive than other surgical methods but 
because it is difficult to measure portal pressure and impossible to 
visualise the splanchnic viscera, there is a risk of portal hypertension.
Surgical procedures
The techniques for extrahepatic PSS attenuation and their common 
locations are outlined by Swalec Tobias and others (1998). The surgical 
procedures are relatively standard, with only the method of PSS 
attenuation varying between surgeons. Hunt and Hughes (1999) reported 
on the outcome of 49 dogs ligated with silk, finding a mortality rate of 2.1 
per cent and that outcome after partial ligation was related to surgeon 
experience.
Intrahepatic PSS can vary in location, morphology and amount of 
parenchymal coverage. This has meant a variety of different procedures 
have been described, categorised as extravascular or intravascular 
techniques. Extravascular techniques involve either ligation of the porta! 
vein branch leading into the PSS, the vessel itself, or the hepatic vein 
which drains the PSS. Breznock and others (1983) described the 
techniques of portal vein branch ligation which can be used for PSS of 
any division, and the technique of placing a ligature around the vessel as 
it entered the hepatic vein cranial to the liver. The portal branch ligation
technique may require some parenchymal dissection, which carries a risk
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of haemorrhage and makes this method far from ideal. The second 
technique is usually restricted to left divisional PSS, which drain into the 
left hepatic vein, the only easily accessible vein cranial to the liver. This 
technique is quick and relatively free of complications and is the 
technique of choice even today for left divisional PSS (White and others, 
1998). Wrigley and others (1983) used intraoperative ultrasound to 
visualise the PSS before ligating it without parenchymal dissection. Martin 
and others (1986) reported the technique of ligating the left hepatic vein 
or ampulla instead of the shunting vessel. This may sometimes be more 
easily accessible but has deleterious, albeit temporary and not life 
threatening, effects on the lobes drained by this vein (Payne and others, 
1991). One of the major risks of extravascular techniques is haemorrhage 
from the parenchyma or torn vessels. To overcome this Swalec Tobias 
and others (1996) outlined the use of an ultrasonic aspirator, which 
selectively destroys parenchyma while leaving blood vessels and bile 
ducts intact.
The ideal technique for PSS attenuation would seem to be to directly 
close the shunting vessel, rather than the portal or hepatic vein, and to 
reduce tissue dissection to an absolute minimum. It was with these goals 
in mind that the intravascular techniques were developed.
Rawlings and Wilson (1983) and Breznock and others (1983) described 
two similar intracaval techniques for closure of intrahepatic PSS. Both 
techniques utilised a longitudinal venotomy in the posthepatic vena cava 
to allow visualisation of the PSS opening before partially closing it with 
polypropylene sutures. In the second method, an additional suture with 
the ends outside the lumen of the vena cava allowed further vessel 
closure after the venotomy was repaired. These procedures are 
technically demanding and time consuming, but considerably reduce the 
risks of haemorrhage.
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A similar technique of PSS attenuation via portal venotomy has been 
reported (Hunt and others, 1996). Total hepatic vascular occlusion was 
achieved and a portal venotomy made longitudinally in the dilated part of 
the portal vein branch supplying the PSS. A single mattress suture was 
passed, at right angles to the venotomy incision, through the lumen of the 
PSS. The suture was passed through Teflon-felt pledgets at each end 
and the ends left untied. The venotomy was closed with a continuous 
suture before the ligature was tightened. The final degree of ligation was 
decided with reference to portal pressure, CVP, arterial blood pressure 
and the appearance of the splanchnic viscera. This technique has also 
been used in two dogs with multiple congenital intrahepatic PSS which 
had a single opening into the portal vein (Hunt and others, 1998b).
White and others (1998) reported on a series of 45 dogs with intrahepatic 
PSS operated on using several of the above techniques and found a 
mortality rate of 18 per cent. These procedures were originally described 
for dogs but several have been used in cats (White and others, 1996b)
Due to the difficulty of partially ligating intrahepatic PSS and the 
possibility of rupturing the vessel (requiring total ligation), two methods of 
surgically creating an extrahepatic shunting vessel have been described, 
allowing easier control of attenuation. White and others (1996a) used an 
autologous jugular vein graft as an extrahepatic portocaval shunt in two 
dogs undergoing central divisional PSS ligation. This allowed total closure 
of the window-like PSS. Poy and others (1998) described a technique of 
creating a splenocaval shunt by end-to-side anastomosis of the splenic 
vein to the CVC. This technique can be used as an emergency procedure 
if a vessel ruptures which must be totally ligated to stop haemorrhage. 
Both of these procedures may require a second operation to close the 
surgically created PSS.
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Complications
Several reports of large numbers of cases have discussed complications 
and their rate of occurrence (Johnson and others, 1987; Mathews and 
Gofton, 1988; Komtebedde and others, 1991; White and others, 1998; 
Hunt and Hughes, 1999; Wolschrijn and others, 2000). Intraoperative 
complications consist of anaesthesia related problems (2 of 33), arterial 
hypotension (8 of 13), hypothermia (5 of 33), acute hepatic congestion (6 
of 13), haemorrhage (3 of 13 and 1 of 33) and vessel rupture during 
intrahepatic PSS dissection (3 of 45). After recovery from anaesthesia the 
most common problems are portal hypertension, neurological problems, 
hyperthermia and abdominal haemorrhage. Portal hypertension manifests 
itself in a number of ways depending on the severity. Mild signs are 
abdominal distension, self-limiting ascites which progress through 
abdominal pain to cardiovascular collapse and arrest or, in severe cases, 
sudden death. Most cases of portal hypertension are thought to be due to 
excessive attenuation of the shunt vessel although many animals appear 
to have had portal pressures within the recommended limits at surgery. 
Another possible cause is portal vein thrombosis and several reports of 
this condition exist. Roy and others (1992) reported two (of sixteen) 
cases, one intrahepatic and the other extrahepatic, both of which had 
been fully ligated and subsequently died acutely. Mathews and Gofton 
(1988) outlined a similar case which underwent full ligation and died 
acutely after 48 hours. All these cases underwent post mortem 
examination which revealed the thrombus. It is possible that other cases 
of portal hypertension which do not undergo further investigation may be 
caused by this condition. The incidence of portal hypertension may 
decrease with greater experience of assessing PSS attenuation 
intraoperativeiy, and this seems to be borne out in the decreased 
incidence in some of the larger case series (White and others, 1998; Hunt 
and Hughes, 1999; Wolschrijn and others, 2000). Neurological problems 
separate from any encountered preoperatively are quite a common 
complication and, if they progress to uncontrollable seizures, can be fatal. 
Hunt and Hughes (1999) found neurological signs as their most frequent
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complication describing them as 'postligation neurological dysfunction’. 
Tisdali and others (2000) investigated this further and found no evidence 
of hypoglycaemia or hyperammonaemia to explain the syndrome. They 
found phenobarbitone administration appeared to reduce the progression 
of mild neurological dysfunction to status epilepticus.
Anaesthesia
Animals with PSS can be difficult to safely anaesthetise, due to their 
impaired liver function. With careful consideration of agents and diligent 
monitoring the risks can be greatly reduced. The liver is used to 
metabolise many anaesthetic drugs so preference should be given to 
those drugs which undergo minimal metabolism by the liver or those 
which can be easily reversed. The main agents which fall into these 
categories are isoflurane, opioid analgesics and propofol (Raffe, 1992). 
Monitoring of arterial blood pressure, CVP and end tidal carbon dioxide 
levels are very useful in detecting signs of cardiovascular instability 
before, during and after PSS attenuation. Blood glucose concentration 
should be monitored frequently because small dogs especially have 
difficulty regulating this and both hypoglycaemia and hyperglycaemia can 
be harmful to the patient (Butler and others, 1990). Core temperature 
should be monitored and maintained as close to normal as possible, as 
anaesthesia impairs normal thermoregulation.
Methods of assessment of the HPV
The HPV is extremely difficult, if not impossible, to objectively measure in 
a live animal. Possible options might include three dimensional computed 
tomography or magnetic resonance imaging to measure the volume of 
the vessels. It might be possible to quantify its volume post mortem but 
this would be unlikely to be reliable. It was for this reason that a 
subjective assessment was chosen. Several methods of measuring 
subjective criteria such as pain, pain relief and lameness have been 
described in the medical and veterinary literature. Human pain
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assessment is the most common subject for which they have been 
utilised. The methods range from simple descriptive scales using four or 
five verbal descriptions (none, mild, moderate, severe, very severe), 
through numerical rating scales giving values from 0 to 10 or 0 to 20, to 
visual analogue scales or graphical rating scales (Downie and others, 
1978). The VAS usually utilises a 100 mm line with perpendicular lines at 
each end, a verbal description of each end-point is placed at these 
extremes and the observer marks a point on the line corresponding to 
their assessment of the subject. The graphical rating scale is a VAS with 
further descriptive terms placed along the line. Visual analogue scales 
have been utilised with success in assessment of pain in humans and 
domestic animals (Reid and Nolan, 1991) and in lameness assessment of 
domestic animals (Welsh and others, 1993). It is considered to be an 
accurate and reproducible method for the assessment of a subjective 
criterion such as pain. The technique is considered as reliable as and 
more sensitive than a simple descriptive scale (Joyce and others, 1975).
39
Hypotheses
This study aims to examine the following hypotheses:
The portal venous system demonstrated on a post-occlusion PVG is 
significantly different from the portal venous system shown on a pre­
occlusion PVG.
Hypoplasia I atresia of the portal venous system can only be diagnosed 
using a post-occlusion PVG.
The novel OSS will give comparable results to the subjective VAS.
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Materials and Methods
Case Details
The surgical records and videotaped angiographic studies of 100 
consecutive dogs and cats treated surgically for the attenuation of a PSS 
at the Queen Mother Hospital for Animals, Royal Veterinary College and 
Davies White Veterinary Specialists between 1997 and 2000 were 
reviewed.
The surgical records were examined for details of the species, breed, age 
at surgery, sex, type of PSS and degree of ligation (partial or full).
The video records consisted of a ventrodorsal (VD) PVG used to identify 
the location of the PSS and a second PVG obtained after temporary full 
occlusion of the shunting vessel. The HPV was assessed by two different 
methods - a subjective VAS and a novel OSS.
Scoring Systems
VAS scores were produced by making a mark on a 100 mm scale 
corresponding to the degree of HPV visualised. Factors taken into 
account when using the VAS are the degree of branching of the HPV, the 
rate at which the HPV fills with contrast, the width of the vessels, the rate 
at which contrast cleared and the degree and rate of parenchymal 
opacification. The end points of the scale were defined as 0 mm, showing 
no evidence of a portal vein entering the liver and 100 mm showing 
normal HPV. A well developed HPV, such as that shown in Figure 4, will 
show rapid filling of a well branched, relatively wide vascular tree with 
good opacification of the parenchyma, which is then rapidly cleared by 
the liver. The marks were then measured and recorded as the number of 
millimetres from the zero end-point. The VAS data were recorded to the 
nearest 1.0 mm.
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Figure 4: Ventrodorsal intraoperative mesenteric portovenogram demonstrating a well 
developed hepatic portal vasculature
The OSS consisted of thirteen questions with a 'yes’ or ‘no’ answer 
devised to assess the development of the HPV (Table 2). A point was 
scored for each ‘yes’ answer giving a possible total of 13 points. When 
directly comparing the OSS with the VAS these results were converted to 
a figure out of 100.
Table 2: Objective scoring system questions. Key: Yes=1 No=0
Is there a portal vein entering the liver? Yes/No
Can we see the right principal branch? Yes/No
Can we see the left principal branch? Yes/No
Can we see branching to the right medial lobe? Yes/No
Can we see branching to the left lobes? Yes/No
In the right branches (right medial and lateral) -
Can we see primary arborisation? Yes/No
Can we see secondary arborisation? Yes/No
Can we see tertiary arborisation? Yes/No
In the left branches -
Can we see primary arborisation? Yes/No
Can we see secondary arborisation? Yes/No
Can we see tertiary arborisation? Yes/No
Is there opacification to the right side of the liver? Yes/No
Is there opacification to the left side of the liver? Yes/No
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Exclusions
Animals were excluded from the study if both pre-occlusion and post­
occlusion PVGs were not present and of diagnostic quality, or if the 
surgical records were incomplete.
Observer Trials
To assess inter-observer variability, 40 PVGs were randomly selected 
and scored by both observers using both scoring systems. Both 
observers were experienced in the assessment of PVGs. Neither 
observer was aware of the score assigned by the other, and the VAS and 
OSS scores were recorded separately.
A further 20 PVGs were selected at random and scored as described 
above, on two separate occasions, one hour apart, to investigate the 
between-observer and within-observer variability of both scoring systems.
Investigative Method
Each animal underwent a full clinical examination and blood samples 
were collected for routine haematological and biochemical evaluation. 
Diagnosis was initially based on signalment, history, physical 
examination, pre- and post-prandial serum bile acid concentrations, 
abdominal ultrasonography and, in some animals, portal scintigraphy. 
Intraoperative portovenography was performed immediately prior to, and 
immediately following, temporary PSS occlusion.
Portovenography
The portovenography technique was consistent for each individual. 
Animals were premedicated with 0.02 mg/kg acepromazine maleate 
(AGP; G-Vet Veterinary Products) and 1 mg/kg pethidine hydrochloride 
(Pethidine injection; Martindale Pharmaceuticals) both given by
intramuscular injection. Anaesthesia was induced by mask with isoflurane
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(Isoflo vet; Schering-Plough Animal Health) vaporised in an oxygen and 
nitrous oxide carrier gas. Once unconscious the animal was intubated 
and maintained using the same agents. Perioperative antibiosis was 
provided with ampicillin (Penbritin Veterinary Injectable; SmithKline 
Beecham Animal Health) 20 mg/kg administered intravenously and an 
arterial catheter (Jelco; Critikon) was placed percutaneously into the 
dorsal metatarsal artery allowing arterial blood pressure to be monitored 
directly. A central venous catheter was placed into the external jugular 
vein allowing CVP to be monitored. Intravenous fluids (0.18 per cent 
saline with 4 per cent glucose) were administered at a sufficient rate to 
maintain central venous and arterial blood pressures within normal limits.
A cranial midline celiotomy was performed and a loop of jejunum was 
exteriorised allowing a jejunal vein to be catheterised using a 20 or 22 
gauge over-the-needle cannula (Jelco; Critikon). The mesenteric venous 
pressure was estimated by saline manometry before mesenteric 
portovenography was performed using a mobile C-arm fluoroscope with 
image intensification (Phillips BV22; Phillips Medical Systems) to obtain 
VD and in some cases lateral images of the cranial abdomen. The 
fluoroscope was connected to a video recorder for image storage, lohexol 
(Omnipaque 350; Nycomed) was injected as a 3-15 ml bolus into the 
catheterised mesenteric vein ensuring that the total dose of iodine did not 
exceed 600 mg/kg.
The PSS was identified and a ligature of 2-0 polypropylene (Prolene; 
Ethicon) was passed around the vessel allowing the vessel to be 
temporarily occluded with a Rummel tourniquet. The mesenteric venous 
pressure was again estimated and a second PVG was obtained. Central 
venous, arterial and portal pressure measurements, effects on splanchnic 
viscera and the results of portovenography were all assessed to 
determine the degree of attenuation the animal could tolerate. The PSS 
was then ligated with two or three 0 silk (Mersilk; Ethicon) ligatures. In 
some animals a polypropylene ligature would also be placed to allow
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further attenuation of the PSS if a subsequent surgery was required. A 
liver biopsy was obtained and the celiotomy incision was repaired 
routinely.
Data Collection
The 200 PVGs obtained from the 100 animals were assessed by one 
observer. For each animal, two images were reviewed, the first prior to 
any manipulation of the shunting vessel and the second following its 
temporary, complete occlusion. Each PVG was assessed using both the 
OSS and VAS.
Statistical Analyses
The assessment of the PVGs provided a score before and after PSS 
occlusion for the OSS and the VAS. The results of these PVG scores 
were analysed using Minitab (Minitab Ltd) and Statistix (Analytical 
Software).
All data obtained using both the VAS and the OSS was assessed for 
Normal distribution.
The statistical significance of the differences between observers when 
assessing the same PVG using the VAS was determined by the use of 
the paired Student’s Ttest. Differences within the same observer when 
scoring the same PVG on two occasions were also analysed using the 
paired Student’s f-test. When comparing these results for the OSS the 
Wilcoxon signed rank test was used.
The repeatability of the two scoring systems was quantified using the 
methods of Bland and Altman (1999). A repeatability coefficient was 
calculated for both the VAS and OSS using the formula: 1.96 * V2 * SD. 
The repeatability coefficient is the value within which two scores of the 
same PVG will lie for 95 per cent of those observations when scored
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using the same scoring system by the same observer. These coefficients 
were used to assess whether any lack of agreement between the 
methods was explained by poor repeatability.
The data for both observers in the between- and within-observer trials 
were combined to allow assessment of reproducibility. Graphical 
techniques were used to plot the difference between the measurements 
obtained by each observer against their mean values. A reproducibility 
coefficient was calculated, using the formula: 1.96 * V2*  SD, for both the 
VAS and the OSS. The reproducibility coefficient is the value within which 
two scores of the same PVG will lie for 95 per cent of those observations 
when scored by the two observers using the same scoring system. These 
were used to quantify the reproducibility of the scoring systems.
The two scoring systems were compared using the method comparison 
techniques described by Bland and Altman (1999) to assess bias, 95 per 
cent limits of agreement and interchangeability. Graphical techniques 
were used to plot the difference between measurements by the two 
scoring methods for each PVG against their mean value. The 95 per cent 
limits of agreement were produced using the formula: mean ± 1.96*SD. 
Acceptable limits of agreement were defined in advance as 15.4 units in 
either direction. This is equivalent to two questions in the OSS.
The statistical significance of the differences between the pre- and post­
occlusion scores for both scoring systems was assessed using the 
Wilcoxon signed rank test.
Animals which had a PVG score of 10 units or less using the VAS or 1 or 
less using the OSS were described as having portal hypoplasia or 
atresia. The post-occlusion PVGs of animals with apparently hypoplastic 
HPV on their pre-occlusion PVG were examined to assess the usefulness 
of the pre-occlusion PVG.
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The Mann-Whitney U test was used to assess the statistical significance 
of the differences between animals undergoing full ligation of their PSS 
and those tolerating only partial ligation. This test was performed for both 
scoring systems, before and after temporary PSS occlusion.
The 95 per cent confidence intervals of the median score were calculated 
for the groups undergoing partial and full ligation in an attempt to produce 
ranges within which full ligation will be safe. These ranges were 
compared with the minimum scores of successful full ligations.
In all analyses statistical significance was set at P<0.05.
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Results
Case Details
One hundred animals (80 dogs and 20 cats) met the inclusion criteria. 
The most common breeds of dog were the Irish wolfhound, the Yorkshire 
terrier and the West Highland white terrier. The most common cat breeds 
were the domestic short hair and the Persian. The breed distributions of 
the dogs and cats are shown in Tables 3 and 4.
Table 3: Breed distribution of dogs studied (only breeds represented more than once 
included)
Breed Number
Irish wolfhound 8
Yorkshire terrier 8
West Highland white terrier 7
Labrador retriever 6
Shih tzu 6
Golden retriever 5
Norfolk terrier 5
Border collie 4
Cairn terrier 4
Irish setter 4
Maltese terrier 3
Bichon frise 2
Jack Russell terrier 2
Miniature schnauzer 2
Other breeds 14
Total 80
Table 4; Breed distribution of cats studied
Breed Number
Domestic short hair 6
Persian 4
British short hair 3
Siamese 3
Domestic long hair 1
Havana 1
Rag doll 1
Tonkinese 1
Total 20
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The mean age at the time of surgery was 15.9 months (range 2 to 108 
months, SD 20.4) for dogs, 14.8 months (range 4 to 48 months, SD 13.0) 
for cats with a combined mean of 15.7 months (range 2 to 108 months, 
SD 19.1). Figures 5 and 6 show the distribution of the ages of dogs and 
cats. The majority of dogs studied were under 12 months of age and the 
majority of cats less than 24 months old.
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Figure 5: Distribution of age at surgery for dogs studied
1
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Figure 6: Distribution of age at surgery for cats studied
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The overall ratio of sex distribution for dogs and cats was 1:1 (Table 5).
Table 5: Sex distribution of dogs and cats studied
Sex Number of dogs Number of cats Total
Male 38 12 50
Female 42 8 50
Total 80 20 100
Of the PSS recognised in the dog, 64 per cent were extrahepatic, 34 per 
cent were intrahepatic and two PSS involved the umbilical vein. Of these, 
the commonest extrahepatic PSS was the portocaval (80 per cent) and 
the commonest intrahepatic PSS was the PDV (85 per cent). This data is 
presented in Table 6.
Table 6; Type of portosystemic shunt identified in dogs
Shunt Type Number
Extrahepatic 51
Portocaval 41
Portoazygos 5
Left gastric vein 4
Colonic vein 1
Intrahepatic 27
Patent ductus venosus 23
Right divisional 2
Central divisional 1
Left divisional 1
Umbilical vein (intra/extrahepatic) 2
Total 80
In cats, an even greater proportion of PSS identified were extrahepatic 
(85 per cent). Of these, the left gastric to caudal vena cava was most 
frequently observed (65 per cent) (Table 7).
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Table 7: Type of portosystemic shunt identified in cats
Shunt Type Number
Extrahepatic 17
Left gastric vein 11
Portocaval 6
Intrahepatic 3
Patent ductus venosus 3
Total 20
With regards to the degree of attenuation achieved at surgery, in the 
majority of cases only partial PSS attenuation was possible (80 per cent 
of dogs and 70 per cent of cats) (Table 8).
Table 8: Degree of ligation of portosystemic shunt in dogs and cats
Degree of ligation Number of dogs Number of cats Total
Full ligation 16 6 22
Partial ligation 64 14 78
Total 80 20 100
Inter-observer differences (reproducibility)
Normal probability plots for the VAS scores obtained for the 80 
portovenograms from the two trials indicated that the scores for both 
observers were not Normally distributed. A Normal probability plot for the 
differences between the VAS scores of the same portovenogram by the 
two observers confirmed this data to be Normally distributed.
Using the VAS, the mean difference between the two observers was 0.36 
units (range -15 to 18 units, SD 6.44). Statistical analysis showed the 
difference between the two observers when scoring the same PVG using 
the VAS was not statistically significant (P=0.62).
The reproducibility coefficient for the VAS was 17.85 units.
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The mean score of the VAS for both observers when scoring the 80 
portovenograms was plotted against the difference in scores for each 
observer (Figure 7). This data demonstrated no error due to magnitude, 
that is, the difference between the scores did not increase with an 
increase in the mean score. Figure 7 also showed that there was greater 
agreement between the two observers at the extremities of the VAS.
1i 5 ------ #oc
9^  ♦  ^IK)
8C  W  - 1 0
2
-15 ♦ -
-20
Mean visual analogue scale score of both observers
Figure 7: Graph of the difference between observers' visual analogue scale scores plotted 
against their mean score
Using the OSS, the scores of the two observers assessing the same PVG 
were identical. There was, therefore, no statistical difference between the 
two observers when scoring the same portovenogram using the OSS and 
the reproducibility coefficient for this OSS data was zero.
Within-observer differences (repeatability)
Normal probability plots for the VAS scores obtained for the 20 
portovenograms that were scored on two separate occasions indicated 
that the scores for both observers were not Normally distributed. A 
Normal probability plot for the differences between the VAS scores of the
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same portovenogram by the same observer confirmed these data to be 
Normally distributed.
The mean difference between the scores recorded at two separate 
instances was -1.4 units (range -14 to 11 units, SD 6.47) for observer 1 
and -0.55 units (range -5 to 4 units, SD 2.98) for observer 2. Statistical 
analysis showed no significant difference for either observer (observer 1, 
P=0.35 and observer 2, P=0.42) between the scores of the same 
portovenogram on two separate occasions.
Repeatability coefficients were 17.9 units (observer 1) and 8.3 units 
(observer 2).
When using the OSS, the scores for the same portovenograms on two 
separate occasions were identical, therefore no statistical difference was 
found and the repeatability coefficients were both zero.
Comparison of scoring systems
Following conversion of the OSS scores to a value out of 100, the mean 
difference between the two scoring systems was -11.0 units (range -5 5  to 
22 units, SD 12.1).
The mean score of the two systems was plotted against the difference 
between the scores (Figure 8). This showed no error due to magnitude, 
that is, the difference did not increase as the mean score increased.
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Figure 8: Graph of difference between visual analogue scale and objective scoring system 
scores plotted against their mean score for 200 portovenograms. Key: Solid line indicates 
mean difference In scores. Dashed lines Indicate 95 per cent limits of agreement of the two 
scoring systems
The 95 per cent limits of agreement of the two scoring systems were 
calculated to be 12.7 and -34.8 units.
Assessment of HPV on pre-occlusion and post-occlusion PVGs
Normal distribution of both pre-occlusion and post-occlusion data using 
the VAS was not demonstrated (Figure 9). The median score for the pre­
occlusion VAS was 4.5 units (range 0 to 88 units) and for the post­
occlusion VAS it was much higher at 53 units (range 2 to 100 units). 
Statistical analysis of these VAS data showed that pre-occlusion and 
post-occlusion scores were significantly different (P<0.01 ).
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Figure 9: Distribution of pre-occlusion and post-occlusion VAS scores
Normal distribution of both pre-occlusion and post-occlusion data using 
the OSS was not demonstrated (Figure 10). The median score for the 
pre-occlusion OSS was 2 units (range 0 to 13 units) and for the post­
occlusion OSS was also higher at 9 units (range 2 to 13 units). Statistical 
analysis of these OSS data showed that pre-occlusion and post-occlusion 
scores were significantly different (P<0.01 ).
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Figure 10: Distribution of pre-occlusion and post-occluslon OS scores
When using the VAS, 62 animals had HPV scores of 10 or less and were 
thus designated as showing evidence of portal atresia or hypoplasia.
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Interestingly, for these individuals their median post-occlusion score was 
much higher at 41 units (range 2 to 98 units). This post-occlusion VAS 
data is presented in Figure 11.
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Figure 11: Distribution of post-occlusion VAS scores of animals with apparently 
hypoplastic pre-occlusion HPV (n»62)
When using the OSS, 39 animals had OSS scores of 0 or 1 and were 
also designated as having portal atresia or hypoplasia. Similarly, for these 
individuals their median post-occlusion score was much higher at 8 units 
(range 2 to 13 units). This post-occlusion OSS data is presented in Figure
12.
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Figure 12: Distribution of post-occlusion OS scores of animals with apparently hypoplastic 
pre-occlusion HPV (n®39)
Figure 13 and 14 show pre- and post-occlusion PVGs of the same 
animal. This demonstrates an extrahepatic PSS with minimal apparent 
HPV development on the pre-occlusion study and a significantly 
improved, although still poor, HPV after PSS occlusion.
Figure 13: Ventrodorsal intraoperative mesenteric portovenogram before temporary 
occlusion of the shunting vessel
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Figure 14: Ventrodorsal Intraoperative portovenogram of the same animal as Figure 13, 
after occlusion of the portosystemic shunt
Comparison of HPV between animals with full and partial ligation
Normal probability plots of the pre- and post-occlusion scores of animals 
with full or partial ligation of their PSS, using either scoring system did not 
demonstrate a Normal distribution for any data sets.
A greater number of animals with partial ligation of their PSS had VAS 
scores at the lower end of this scale, whereas for animals with full 
ligations the distribution was more evenly distributed. For clarity this data 
is presented as the number of animals in each group, as a percentage, 
against their respective pre-occlusion VAS score, in Figure 15.
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Figure 15: Distribution of pre-occlusion visual analogue scale scores of animals 
undergoing partial and full ligation of their portosystemic shunt
Conversely, similar data for post-occlusion VAS scores shows an even 
distribution of partial ligation scores with the full ligation data distributed at 
the higher end of the scale. This information is similarly presented in 
Figure 16.
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Figure 16: Distribution of post-occlusion visual analogue scale scores of animals 
undergoing partial and full ligation of their portosystemic shunt
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When using the OSS, the data for pre-occlusion scores shows the partial 
ligation scores are distributed at the lower end of the scale while the full 
ligation scores are more evenly distributed but towards the higher end 
(Figure 17).
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Figure 17: Distribution of pre-occlusion objective scoring system scores of animals 
undergoing partial and full ligation of their portosystemic shunt
Post-occlusion OSS data shows a more even distribution of partial 
ligation scores but the full ligation scores are largely confined to the upper 
scores (Figure 18).
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Figure 18: Distribution of post-occlusion objective scoring system scores of animals 
undergoing partial and full ligation of their portosystemic shunt
There was a significant difference between the results of animals with 
partial and full ligation of their PSS using either scoring system, both 
before and after temporary PSS occlusion (P<0.01 for all four tests).
Using the above data, the 95% confidence intervals of the median VAS 
scores were calculated for animals with partial and full ligation of their 
PSS for PVGs both before and after occlusion of their PSS. The 95% 
confidence intervals of the median OSS scores were calculated similarly. 
These results are presented in Table 9.
Table 9: 95 per cent confidence intervals of pre- and post-occluslon scores for animals with 
partial and full ligation of their portosystemic shunt, using both scoring systems
Partial ligation Full ligation
Pre-occlusion VAS 3 .0 -9 .5 31.5-60.5
Post-occlusion VAS 39.5 -  54.0 80.0 -  96.0
Pre-occlusion OS 1 .5 -2 .5 5.0 — 9.0
Post-occlusion OS 7 .5 -9 .0 12.5-13.0
Examination of the post-occlusion scores show the lowest HPV score of 
an animal which tolerated full ligation of its PSS was 41 units using the
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VAS and 6 units with the OSS. These figures are significantly lower than 
the low 95% confidence interval for each scoring system.
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Discussion
This is the first study which has attempted to quantitatively assess the 
HPV in a large group of dogs and cats with PSS. The development and 
assessment of the two scoring systems enabled reproducible and 
repeatable evaluation of intraoperative mesenteric PVGs. A number of 
previously reported studies have subjectively described the appearance 
of PVGs in animals with a PSS (Gofton, 1978; Wrigley and others, 1987; 
Martin and Payne, 1990; Swalec and Smeak, 1990; Swalec Tobias and 
others, 1996; White and others, 1996b; White and others, 1998). These 
methods are, however, unsatisfactory when comparing large numbers of 
PVGs both pre- and post-ligation. The variability of reported assessment 
methods makes comparison of data from these studies difficult. Previous 
assessment techniques remain crude, which is understandable given that 
data provided by a dynamic PVG lends itself to subjective rather than 
objective analysis. A form of precise and, ideally, objective measurement 
of portal vasculature development both prior to and following shunt 
attenuation is, therefore, highly desirable in the short and long term 
assessment of PSS in the dog and cat. It should, therefore, provide an 
ideal starting point on which to base further investigations of the effects of 
the various therapeutic interventions which are now available for the 
surgical management of PSS.
Several problems with the investigative method were identified during the 
study. True blind assessment was not possible because an experienced 
observer will recognise the shunting vessel on a pre-occlusion PVG, and 
an occluded shunting vessel on a post-occluslon PVG. This may 
introduce an element of bias, assigning higher VAS scores to post­
occlusion PVGs. This bias should not apply to the OSS, as structures are 
either present or absent. It would be extremely difficult to negate this 
problem as this would require the PSS and the CVC to be edited out of 
the stored video image. This study was retrospective in nature and as
such the decision whether to fully or partially ligate the PSS was made at
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the time of surgery. In most cases the post-occlusion HPV development 
was one of several factors used to determine the degree of possible 
ligation, thus selecting for higher scores in those animals which tolerated 
full ligation. Only in a prospective study in which the surgeon had no 
opportunity to view the PVGs prior to making a decision on degree of 
shunt attenuation would this element of bias be eliminated. Those 
animals which underwent partial ligation of their PSS did so because the 
surgeon believed that full ligation of the vessel was unsafe. It is possible 
that in some of these cases, full ligation could have been safely tolerated 
and, therefore, the number of partial ligations performed may have been 
greater than was necessary. Again this may have produced an error in 
the interpretation of the results. Comparisons between intrahepatic and 
extrahepatic PSS will be skewed when using the OSS. Intrahepatic PSS 
all have a visible extrahepatic portal vein on PVG, whereas this does not 
apply to all animals with extrahepatic PSSs. This will increase the score 
of an intrahepatic PSS compared with an extrahepatic PSS with identical 
development of their HPV. This is particularly evident in individuals with 
PVGs scoring at the low end of the OSS, as in effect no animal with an 
intrahepatic PSS can score zero on the OSS. In this study the animals 
with intrahepatic PSS are not representative of the complete population of 
animals with this condition, as those individuals with a central divisional 
PSS were excluded from the study since the intravascular techniques 
required to close their shunts do not allow the performance of a post­
occlusion PVG.
Although the two scoring methods used in this study are considerably 
more refined than those previously reported, some problems were 
encountered. The lack of statistical difference in the results of the inter­
observer studies and the low reproducibility coefficients confirmed that 
both scoring systems had acceptable reproducibility. Good reproducibility 
is important when measuring a clinical parameter because it ensures 
validity in comparison of scores obtained by different observers. With 
poor reproducibility, an observer may produce a series of highly
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repeatable scores that are still not comparable with results obtained from 
other centres or observers. Although the VAS had good reproducibility, it 
was interesting to note that the differences between the observers were 
greatest for values near the centre of the VAS and, conversely, the 
scores were found to be most similar at both the low and high ends of the 
scale. This is a recognised phenomenon in the use of a VAS, and it is 
suggested that scores falling in the region ± 20 mm of the centre point of 
the VAS line cause the most difficulty in both reproducibility and 
repeatability (Welsh and others, 1993).
The results of the within-observer studies confirmed that both scoring 
systems had excellent repeatability. The repeatability of a measurement 
is fundamental in ensuring that a measurement system is useful. If 
changes in a clinical parameter are to be measured over time, it is vital 
that any observed changes in the measured parameter are due to 
alteration in that variable and not due to variation in the accuracy of the 
scoring system. From the point of view of repeatability, both scoring 
systems appeared to be applicable to the assessment of dynamic 
intraoperative mesenteric portovenography. The fact that both scoring 
systems were highly repeatable was also of importance when 
consideration was given to a comparison of the two systems. If one or 
both of the scoring systems had poor repeatability, it would have proved 
difficult to compare the two systems. When evaluating a new scoring 
system with respect to a previously accepted system, if the older system 
has poor repeatability, even a perfectly accurate new system will have 
poor agreement. This lack of agreement might imply that the new scoring 
system Is inaccurate when, in fact, the problem actually lies with the poor 
repeatability of the older, accepted system. Fortunately, in this study both 
scoring systems had a high level of repeatability and, therefore, a 
comparison between the two systems was considered both appropriate 
and meaningful. Assessment of the repeatability of portovenography itself 
was not performed, this would require repeated PVGs of the same animal
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under similar conditions, which was not possible due to the retrospective 
nature of the study.
The two scoring systems were compared using a previously described 
method (Bland and Altman, 1999). This method measures the agreement 
between two systems which both measure a quantity of which the true 
value is not known. The ‘new’ system of measurement is compared to an 
‘established’ system which itself may not provide a correct measurement. 
The method provides for assessment of how much the ‘new’ system 
differs from the ‘established’ system and this can then be used to 
determine whether the two systems are interchangeable. In this study the 
OSS was considered the ‘established’ method of measurement and the 
VAS the ‘new’ system of measurement although both systems were new. 
The results of the comparison between the VAS and OSS confirmed that 
the two scoring systems were not directly interchangeable. There are a 
number of reasons for this. As already eluded to, the degree of 
repeatability of each scoring system may have a profound effect on the 
findings of system comparison. The effect of repeatability was assessed 
by comparing the 95% limits of agreement of the two scoring systems 
with their repeatability coefficients. The repeatability coefficients were 
smaller than the limits of agreement suggesting there was some factor 
other than repeatability that was making the two systems not directly 
interchangeable. Bias was also demonstrated between the two systems, 
with the mean VAS score being 11.4 units higher than the OSS score. 
This, however, also does not completely explain the lack of agreement.
The reliability of both scoring systems may also contribute to their lack of 
interchangeability. Problems with reliability differed for each scoring 
system. For example, although the VAS had acceptable reproducibility, 
there was a central length (± 20 mm of the centre point) over which 
scores were considered less reliable. The conversion of OSS into values 
out of 100 so that the comparison with the VAS could be made produced 
its own set of inaccuracies. Firstly, the OSS produced discrete values
66
between zero and 13, so that even if there were perfect agreement 
between the two systems, there would be a range of VAS scores 
corresponding to a single OSS. This produces an inherent disagreement 
between the two scoring systems. As a factor in producing an overall 
disagreement between the two scoring systems, this was considered of 
little importance because the maximum disagreement for each score 
would only be half of an OSS point, that is, 3.8 units out of 100, well 
within the acceptable limits of agreement. Secondly, each of the 
questions in the OSS system did not represent an equal linear 
progression from the previous question and yet when the OSS scores 
were converted to a score out of 100 they were assumed to progress in 
an equal, linear manner of 7.7 units for each OSS question. For example, 
a portovenogram where there were only major portal branches with no 
arborisation would produce a low score on the visual analogue scale, 
although the same image might produce an OSS score of up to 5 out of
13. This may represent the most likely reason why the two systems 
cannot be directly interchanged.
Despite these inherent problems, the method of Bland and Altman (1999) 
is accepted to be the most appropriate way of quantifying agreement 
providing these limitations are understood. Measuring correlation 
between the two scoring systems would give very high correlation 
coefficients. This is because both systems are measuring the same 
criteria and would be expected to give increasing scores as the HPV 
improves, thus correlating well. Correlation does not give any information 
on whether the systems agree. Complete agreement will place all results 
along a line of equality when plotted against each other whereas results 
which correlate will be placed along any straight line, this can 
misleadingly give the Impression of agreement.
The two scoring systems used in this study were devised for different 
reasons. The overall aim of a scoring system was to give a quantitative 
value for the degree of development of the HPV. The OSS was created to
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provide an objective measurement of the HPV that could be used by any 
individual with knowledge of the normal anatomy of the portal vessels. 
Unfortunately, this scoring system proved to have a number of serious 
deficiencies. Several of the criteria used to interpret PVGs were found to 
be impossible to quantify. For example, it was not possible to quantify the 
degree of opacification of the liver parenchyma using the OSS. The 
system also proved problematic when interpreting intrahepatic shunts, 
such as a patent ductus venosus. Since all intrahepatic shunts emanate 
from either the left or right branch of the portal vein, a number of points 
will be scored on the OSS regardless of their further portal vasculature 
appearance. On the contrary, an extrahepatic shunt with similar portal 
development may have a lower score on the OSS since there may not be 
either a left or right portal vein branch. The OSS also assumes that both 
left and right portal vein branches are equal and symmetric in 
appearance. In the majority of normal Individuals this is not true, with the 
left branch having greater development than the right (Burton and White, 
1999). The VAS was devised because it would allow all gradations of 
portal development, from normal vasculature to complete portal atresia, 
to be assessed subjectively. This scoring system could take account of 
several factors that the OSS failed to assess. For example, the width of 
portal vessels rather than just their presence, the speed with which the 
vessels were observed to fill with contrast medium and the rate at which 
the contrast medium was seen to clear from these vessels. A 
disadvantage of the VAS was that it required the observer to be 
experienced in the assessment of PVGs.
The portovenograms for this study were produced using fluoroscopy and 
recorded on videotape. The procedure was performed in the operating 
theatre itself thus avoiding problems such as increased procedure time, 
hypothermia and loss of sterility associated with movement of the animal 
to a radiography room. The use of fluoroscopy and video storage and 
retrieval removes the possibility of missing the contrast medium outlining 
the vessels which may occur using static films due to sluggish portal
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blood flow, or operator inexperience. A dynamic image of the portal 
vasculature gives a better indication of the flow rate of the contrast and 
allows the point of maximum contrast enhancement to be identified with 
confidence. By utilising video storage and retrieval, the study may be 
reviewed several times while in theatre negating the use of multiple 
contrast medium injections. Routinely only the ventrodorsal projection is 
used, however, if the vessel was unusual in appearance or difficult to 
locate a lateral projection would also be produced. The ventrodorsal view 
provides better information about the anatomical position of both 
intrahepatic and extrahepatic PSS. Several authors consider the use of 
intraoperative portovenography to be unnecessary for experienced 
surgeons due to the relatively common anatomical positions of many PSS 
(Komtebedde and others, 1991; Hunt and Hughes, 1999). Although it is 
often possible to locate the anomalous vessel during surgical exploration, 
a pre-occlusion PVG will provide more information about the morphology 
and location of the vessel than gross observation alone. A post-occlusion 
study will allow verification that the correct vessel has been identified, 
ensure the presence of as second PSS has been ruled out and allow 
assessment of the HPV to exclude portal atresia and assist in the 
decision regarding the degree of shunt attenuation.
In this study the decision whether to fully or partially ligate the PSS was 
made with reference to several factors, including post-occlusion HPV 
appearance, gross observation of splanchnic viscera, systemic arterial 
pressure, central venous pressure and portal pressure. These criteria 
were used in combination with the experience of the surgeon to 
determine the degree of shunt ligation. Although there are published 
figures of recommended post-occlusion portal pressures (Martin and 
Freeman, 1987; Swalec and Smeak, 1990; Bostwick and Twedt, 1995), 
these figures are considered by many authorities to be unreliable (Swalec 
and Smeak, 1990; White and others, 1998). Portal pressure 
measurement is notoriously unreliable due to many factors including 
position of the abdominal viscera, hypothermia, anaesthetic depth,
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splanchnic venous compliance, arterial blood pressure and venospasm in 
the PSS following its manipulation (White and others, 1998). The post­
occlusion PVG gives a visual representation of the perfusion of the liver, 
and is thus a useful additional tool when deciding whether to partially or 
fully ligate a PSS.
This study shows that the HPV visualised on a post-occlusion PVG is 
significantly different to the HPV outlined on a pre-occlusion PVG. This is 
to be expected as the flow of contrast medium (and thus portal blood) 
through the portal vasculature is vastly different when a shunting vessel is 
present compared to when it is occluded. With the PSS patent, it provides 
a route for the contrast to bypass the liver via the caudal vena cava or 
azygos vein. This route is chosen because of the lower pressure found in 
these veins compared to the hepatic portal vasculature with its higher 
resistance. Once the vessel is occluded, the contrast is forced to pass 
through the liver producing a more accurate view of the HPV. It will still 
flow through the path of least resistance producing the differential 
perfusion of the portal vein branches commonly observed. The initial 
degree of HPV visualisation is therefore related to the diameter of the 
PSS and the pressure gradients rather than any portal hypoplasia. With 
portal atresia the contrast will have no path to the liver and will therefore 
pool in the extrahepatic portal vein after PSS occlusion. This may also be 
seen in cases of severe portal vein hypoplasia. Whether the post­
occlusion PVG gives an entirely accurate depiction of the maximum HPV 
depends on whether the hypoplasia is due to anatomical or functional 
factors. If the restriction is physical, with the vessels stretched as wide as 
possible without further growth, then the PVG will be a true 
representation of the HPV. However, if it is a functional problem, with 
sphincters or smooth muscle contraction restricting flow until the portal 
pressure gradually increases, then the PVG may not be accurate.
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The correct diagnosis of portal atresia is essential. Attempting to ligate or 
attenuate the PSS in these animals will, at best, lead to the formation of 
multiple acquired PSS with continued clinical signs, and at worst be fatal. 
Similar problems can occur in animals with severe portal hypoplasia 
which are treated using materials which cause progressive attenuation 
(ameroid constrictors, cellophane bands). If the vessel becomes 
attenuated before the portal vasculature has developed enough to accept 
the increased blood flow then the formation of multiple acquired PSS is 
inevitable, this may explain the higher rate of long-term failure in these 
animals (Vogt and others, 1996) when compared with the use of silk 
(Hunt and Hughes, 1999). While it is important to make the correct 
positive diagnosis, it is also important that surgeons do not, by performing 
only pre-occlusion PVGs, over-diagnose portal atresia and deny many 
animals the benefit of corrective surgery. In this study 62 animals 
appeared to have hypoplastic or atretic portal veins on a pre-occlusion 
PVG using the VAS, of these, 50 showed improved HPV after vessel 
occlusion and all were at least partially ligated successfully.
An attempt was made to define a range of HPV scores for which full 
ligation of the PSS is safe, the 95% confidence intervals this produced 
are relatively narrow and the range of scores quite high. This is partly due 
to the small number of full ligations performed, with more data the ranges 
may become wider and lower values may be indicated. Lower values are 
certain to be safe in some animals as indicated by the lowest safe VAS 
score shown in this trial of 41, and 6 using the OSS, which are both 
substantially lower than their respective confidence intervals. Further 
work could be aimed at more accurately defining these safe limits 
although because several factors are taken into account when deciding 
the safe degree of attenuation for each animal it may not be ethical to use 
the HPV score alone in this decision in clinical cases.
Of the two scoring systems devised, the inherent deficiencies of the OSS 
suggest the VAS will be the most useful system for assessing HPV. With
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a repeatable and reproducible scoring system, it will be possible to more 
accurately track the changes in the HPV due to surgical intervention. This 
would provide an ideal way of monitoring the effectiveness of the different 
methods of surgical attenuation available. If portovenography could be 
performed regularly after attenuation an explanation may be found for the 
different outcomes of attenuation in animals undergoing similar degrees 
and methods of attenuation, that is, why some animals progress to full 
closure of the vessel, some show continued flow through it and others 
form multiple acquired PSS (Burton and White, 2001). Portovenography, 
although more invasive than serum bile acid measurement and portal 
scintigraphy, is more sensitive at diagnosing portosystemic shunting. It 
provides significantly more information about the portal vasculature and 
can provide anatomical details of any continued portosystemic flow. 
Using the HPV scoring system described, it is possible to quantitatively 
assess the changes in the portal vasculature caused by the surgical 
intervention. With this information it may become possible to determine 
which animals are likely to progress to a normal HPV following surgery 
and which animals would not show further HPV development and thus 
would be at risk of developing multiple acquired portosystemic shunts.
In conclusion, both the OSS and VAS demonstrated acceptable 
reproducibility and repeatability when they were used to assess PVGs. 
The OSS had a number of inherent deficiencies that suggested it was not 
the method of choice in the assessment of PVGs. The VAS was 
considered most accurate in the assessment of PVGs characterised by 
either a very well-developed or a very poorly developed portal 
vasculature. Although optimal use of the VAS requires an experienced 
observer, it has been shown to provide a useful method for the 
assessment of the subjective data obtained from PVGs. The HPV 
observed on a post-occlusion PVG is significantly different to that seen 
before the vessel is occluded. This indicates that the HPV visualised on a 
pre-occlusion PVG is unreliable and more likely to be related to the flow 
through the PSS than the development of the portal vasculature. Many
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animais in this study with apparent portal atresia or severe hypoplasia on 
pre-occlusion PVG were shown to have adequate to excellent HPV 
development after occlusion of the PSS.
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Appendix I -  Inter-observer trial
Visual Analogue Scale
Trial Number Observer 1 Observer 2
1 0 0
2 0 1
3 7 5
4 1 0
6 0 0
6 10 15
7 3 5
8 1 0
9 0 1
10 49 60
11 35 23
12 0 0
13 0 0
14 20 12
15 5 7
16 38 45
17 4 6
18 0 1
19 0 0
20 1 1
21 53 47
22 10 16
23 68 78
24 78 69
25 17 20
26 45 58
27 39 31
28 11 17
29 9 10
30 99 97
31 100 99
32 20 15
33 63 57
34 51 64
35 90 84
36 42 51
37 95 98
38 47 32
39 10 15
40 23 18
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Objective Scoring System
Trial Number Observer 1 Observer 2
1 1 1
2 0 0
3 1 1
4 1 1
5 1 1
6 2 2
7 2 2
8 0 0
9 0 0
10 8 8
11 5 5
12 0 0
13 1 1
14 1 1
15 1 1
16 7 7
17 2 2
18 0 0
19 0 0
20 0 0
21 7 7
22 3 3
23 10 10
24 10 10
25 4 4
26 8 8
27 5 5
28 3 3
29 3 3
30 13 13
31 13 13
32 4 4
33 8 8
34 7 7
35 12 12
36 8 8
37 13 13
38 5 5
39 4 4
40 4 4
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Appendix 11 -  Within-observer trial
Visual Analogue Scale
Trial Number Observer 1 Observer 1 +1 hour Observer 2
Observer 2 
+1 hour
1 50 45 45 45
2 76 79 82 78
3 58 60 59 62
4 74 88 79 81
5 61 66 71 73
6 93 95 89 93
7 22 16 20 19
8 80 86 79 76
9 25 32 35 37
10 2 7 3 2
11 33 41 41 38
12 7 3 3 2
13 45 39 35 40
14 40 33 38 41
15 86 93 86 83
16 6 6 2 5
17 34 23 37 41
18 88 95 89 85
19 13 9 22 21
20 90 95 84 88
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Objective Scoring System
Trial Number Observer 1 Observer 1 +1 hour Observer 2
Observer 2 
+1 hour
1 7 7 7 7
2 10 10 10 10
3 8 8 8 8
4 10 10 10 10
5 8 8 8 8
6 12 12 12 12
7 3 3 3 3
8 10 10 10 10
9 3 3 3 3
10 0 0 0 0
11 4 4 4 4
12 1 1 1 1
13 6 6 6 6
14 5 5 5 5
15 11 11 11 11
16 1 1 1 1
17 34 23 37 41
18 88 95 89 85
19 13 9 22 21
20 90 95 84 88
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